Virax Biolabs VRAX
NASDAQ VRAX
$2.23 -0.08 (-3.65%)
At close: Sep 29, 2026 · 4:00 PM EDT

Virax Biolabs (VRAX) Receivables - Net (2021 - 2025)

Updated

Virax Biolabs' Receivables - Net was $729.00 in fiscal Q2 2026 (quarter ended Sep 30, 2025), down 69.1% from $2,361 a year earlier.

Analysis

Virax Biolabs (VRAX) Receivables - Net (2021 - 2025) Analysis & Trends

At the end of FY2021 (ended Mar 31, 2021), Receivables - Net at Virax Biolabs came in at $928.00.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Virax Biolabs 934,336.46 -20.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 729.00
Sep 30, 2024 2,361.00
Mar 31, 2021 928.00
API Access

Virax Biolabs Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=VRAX&period=max&api_key=YOUR_API_KEY